Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension

被引:86
|
作者
Dewachter, Laurence
Adnot, Serge
Fadel, Elie
Humbert, Marc
Maitre, Bernard
Barlier-Mur, Anne-Marie
Simonneau, Gerald
Hamon, Michel
Naeije, Robert
Eddahibi, Saadia
机构
[1] Hop Henri Mondor, AP HP, Dept Physiol, F-94010 Creteil, France
[2] Hop Marie Lannelongue, Serv Chirurgie Thorac Vasc & Transplant Cardiopul, UPRES EA 2705, F-92350 Le Plessis Robinson, France
[3] Hop Antoine Beclere, AP HP, Serv Pneumol, Clamart, France
[4] Univ Paris 06, INSERM, Fac Med Pitie Salpetriere, UMR 677, Paris, France
[5] Free Univ Brussels, Fac Med, Physiol Lab, Brussels, Belgium
关键词
angiopoietin-1; growth factors; idiopathic pulmonary arterial hypertension; pulmonary artery smooth muscle; pulmonary endothelial cells;
D O I
10.1164/rccm.200602-304OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Angiopoietins are involved in blood vessel maturation and remodeling. Objectives: One consequence of endothelium-specific tyrosine kinase-2 (Tie2) receptor activation by angiopoietin-1 (Ang1) is the release of endothelium-derived growth factors that recruit vascular wall cells. We investigated this process in idiopathic pulmonary arterial hypertension (iPAH). Methods: Ang1, Ang2, and total and phosphorylated Tie2 expression (mRNA and protein) was evaluated in human lung specimens and in cultured pulmonary artery smooth muscle cells (PA-SMCs) and pulmonary endothelial cells (P-ECs) isolated from patients with iPAH and control subjects. Media collected from Ang1-treated P-ECs were assessed for their PA-SMC growth-promoting effect. Measurements and Main Results: Tie2 receptor was fourfold higher in lungs and P-ECs from patients with iPAH than in those from control subjects, with a parallel increase in phosphorylated lung Tie2 receptor. In contrast, Ang1 and Ang2 expression in lungs, P-ECs, and PA-SMCs did not differ. Incubation of PA-SMCs with medium collected from P-EC cultures induced marked proliferation, and this effect was stronger when using P-ECs from patients with iPAH than from control subjects. Ang1 pretreatment of P-ECs from either patients or control subjects induced a further increase in PA-SMC proliferation. Fluoxetine, an inhibitor of the mitogenic action of serotonin, reduced the growth-promoting effect of P-EC media. Ang1 added to P-ECs from patients with iPAH increased the production of endothelin-1 (ET-1) and serotonin, but not of plateletderived growth factor-BB orepidermal growth factor, and increased the amount of mRNA encoding tryptophan hydroxylase-1 (the rate-limiting enzyme of serotonin synthesis), preproET-1, and ET-11-converting enzyme. Conclusions: The Ang1/Tie2 pathway is potentiated in iPAH, contributing to PA-SMC hyperplasia via increased stimulation of endothelium-derived growth factors synthesis by P-ECs.
引用
收藏
页码:1025 / 1033
页数:9
相关论文
共 50 条
  • [1] Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway
    Sullivan, CC
    Du, LL
    Chu, D
    Cho, AJ
    Kido, M
    Wolff, PL
    Jamieson, SW
    Thistlethwaite, PA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) : 12331 - 12336
  • [2] The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
    Vanderborght, Bart
    Lefere, Sander
    Van Vlierberghe, Hans
    Devisscher, Lindsey
    CELLS, 2020, 9 (11)
  • [3] Downregulation of angiopoietin-1 and Tie2 in chronic hypoxic pulmonary hypertension
    Yamamoto, Akihito
    Takahashi, Hideki
    Kojima, Yuko
    Tsuda, Yasunari
    Morio, Yoshiteru
    Muramatsu, Masashi
    Fukuchi, Yoshinosuke
    RESPIRATION, 2008, 75 (03) : 328 - 338
  • [4] Targeting the Tie2/angiopoietin signaling pathway in glioblastoma
    Plate, Karl H.
    Scholz, Alexander
    Harter, Patrick
    Mittelbronn, Michel
    van Slyke, Paul
    Dumont, Dan
    Reiss, Yvonne
    CANCER RESEARCH, 2015, 75 (01)
  • [5] Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
    William A Barton
    Dorothea Tzvetkova-Robev
    Edward P Miranda
    Momchil V Kolev
    Kanagalaghatta R Rajashankar
    Juha P Himanen
    Dimitar B Nikolov
    Nature Structural & Molecular Biology, 2006, 13 : 524 - 532
  • [6] The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium
    Anisimov, Andrey
    Fang, Shentong
    Hemanthakumar, Karthik Amudhala
    Ord, Tiit
    van Avondt, Kristof
    Chevre, Raphael
    Toropainen, Anu
    Singha, Prosanta
    Gilani, Huda
    Nguyen, Su D.
    Karaman, Sinem
    Korhonen, Emilia A.
    Adams, Ralf H.
    Augustin, Hellmut G.
    Oorni, Katariina
    Soehnlein, Oliver
    Kaikkonen, Minna U.
    Alitalo, Kari
    NATURE CARDIOVASCULAR RESEARCH, 2023, 2 (03): : 307 - +
  • [7] The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium
    Andrey Anisimov
    Shentong Fang
    Karthik Amudhala Hemanthakumar
    Tiit Örd
    Kristof van Avondt
    Raphael Chevre
    Anu Toropainen
    Prosanta Singha
    Huda Gilani
    Su D. Nguyen
    Sinem Karaman
    Emilia A. Korhonen
    Ralf H. Adams
    Hellmut G. Augustin
    Katariina Öörni
    Oliver Soehnlein
    Minna U. Kaikkonen
    Kari Alitalo
    Nature Cardiovascular Research, 2023, 2 : 307 - 321
  • [8] Targeting the Angiopoietin/Tie2 Pathway: Cutting Tumor Vessels With a Double-Edged Sword?
    Cascone, Tina
    Heymach, John V.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04) : 441 - 444
  • [9] MOVING BEYOND VEGF: INHIBING GLIOMA ANGIOGENESIS BY TARGETING THE TIE2/ANGIOPOIETIN SIGNALING PATHWAY
    Plate, Karl H.
    Scholz, Alexander
    Mittelbronn, Michel
    Harter, Patrick
    Dumont, Daniel
    van Slyke, Paul
    Reiss, Yvonne
    NEURO-ONCOLOGY, 2014, 16
  • [10] Saikosaponin-d regulates angiogenesis in idiopathic pulmonary fibrosis through angiopoietin/Tie-2 pathway
    Wu, Yan
    Zhang, Jun
    Wang, Xintian
    Xu, Yuncong
    Zheng, Jinxu
    ACTA HISTOCHEMICA, 2023, 125 (08)